Search Results - "Mendis, Kamini N."

Refine Results
  1. 1

    A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies by Bosman, Andrea, Mendis, Kamini N

    “…Parasite resistance to conventional antimalarial medicines has led, in recent years, to a dramatic shift in malaria treatment. Sixty-seven countries with…”
    Get more information
    Journal Article
  2. 2

    Evolutionary and Historical Aspects of the Burden of Malaria by CARTER, Richard, MENDIS, Kamini N

    Published in Clinical Microbiology Reviews (01-10-2002)
    “…ERRATUM ( vol. 16 , p. 173 ) Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Mass radical treatment of a group of foreign workers to mitigate the risk of re-establishment of malaria in Sri Lanka by Marasinghe, Manonath M, Karunasena, Vissundara M, Seneratne, Arundika S, Herath, Hema D B, Fernando, Deepika, Wickremasinghe, Rajitha, Mendis, Kamini N, Ranaweera, Dewanee

    Published in Malaria journal (25-09-2020)
    “…Following malaria elimination, Sri Lanka was free from indigenous transmission for six consecutive years, until the first introduced case was reported in…”
    Get full text
    Journal Article
  5. 5

    Spatial targeting of interventions against malaria by Carter, R, Mendis, K N, Roberts, D

    Published in Bulletin of the World Health Organization (01-01-2000)
    “…Malaria transmission is strongly associated with location. This association has two main features. First, the disease is focused around specific mosquito…”
    Get full text
    Journal Article
  6. 6

    Global Epidemiology of Plasmodium vivax by Howes, Rosalind E, Battle, Katherine E, Mendis, Kamini N, Smith, David L, Cibulskis, Richard E, Baird, J Kevin, Hay, Simon I

    “…Plasmodium vivax is the most widespread human malaria, putting 2.5 billion people at risk of infection. Its unique biological and epidemiological…”
    Get full text
    Journal Article
  7. 7

    A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children by Fernando, Deepika, de Silva, Damani, Carter, Richard, Mendis, Kamini N, Wickremasinghe, Rajitha

    “…A double-blind, placebo-controlled trial of nine months duration was carried out to investigate the impact of malaria and its prevention on the educational…”
    Get more information
    Journal Article
  8. 8

    Malaria transmission-blocking vaccines—how can their development be supported? by Carter, Richard, Mendis, Kamini N, Miller, Louis H, Molineaux, Louis, Saul, Allan

    Published in Nature medicine (01-03-2000)
    “…Malaria is a disease of poor countries. The development of malaria vaccines requires considerable investment, for which there is little commercial interest,…”
    Get full text
    Journal Article
  9. 9

    The paroxysm of Plasmodium vivax malaria by Karunaweera, Nadira D., Wijesekera, Subadra K., Wanasekera, Deepani, Mendis, Kamini N., Carter, Richard

    Published in Trends in parasitology (01-04-2003)
    “…The paroxysms of Plasmodium vivax malaria are antiparasite responses that, although distressing to the human host, almost never impart serious acute pathology…”
    Get full text
    Journal Article
  10. 10
  11. 11

    An Indigenous Case of Plasmodium ovale Infection in Sri Lanka by Wickremasinghe, Renu, Galapaththy, Gawrie N. L, Fernando, W. A. P, de Monbrison, Frederique, Wijesinghe, Rushika S, Mendis, Kamini N, Picot, Stephane, Ringwald, Pascal, Wickremasinghe, Ananda R

    “…Plasmodium ovale, which is generally prevalent only in the African region, has been emerging in the Asian and southeast Asian regions. It has not been reported…”
    Get full text
    Journal Article
  12. 12

    Quantifying Genetic and Nongenetic Contributions to Malarial Infection in a Sri Lankan Population by Mackinnon, Margaret J., Gunawardena, D. M., Rajakaruna, Jagath, Weerasingha, Sudath, Mendis, Kamini N., Carter, Richard

    “…Explaining the causes of variation in the severity of malarial disease remains a major challenge in the treatment and control of malaria. Many factors are…”
    Get full text
    Journal Article
  13. 13

    Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria by Peiris, J S, Premawansa, S, Ranawaka, M B, Udagama, P V, Munasinghe, Y D, Nanayakkara, M V, Gamage, C P, Carter, R, David, P H, Mendis, K N

    “…Antibodies against gametes of the malarial parasite inhibit the development of the parasite in the mosquito and curtail the transmission of malaria. We now…”
    Get more information
    Journal Article
  14. 14

    Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response by Holm, Inge, Nato, Farida, Mendis, Kamini N, Longacre, Shirley

    Published in Molecular and biochemical parasitology (01-11-1997)
    “…The major merozoite surface protein-1 (MSP-1) is a leading malaria vaccine candidate. A 200 kDa precursor is processed in two steps giving rise successively in…”
    Get full text
    Journal Article
  15. 15

    Rosetting: a new cytoadherence property of malaria-infected erythrocytes by David, P H, Handunnetti, S M, Leech, J H, Gamage, P, Mendis, K N

    “…Plasmodium fragile infection of the toque monkey is a natural host-parasite association in which parasite sequestration occurs as during P. falciparum…”
    Get more information
    Journal Article
  16. 16

    Uninfected erythrocytes form "rosettes" around Plasmodium falciparum infected erythrocytes by Handunnetti, S M, David, P H, Perera, K L, Mendis, K N

    “…The human malaria parasite, P. falciparum, exhibits cytoadherence properties whereby infected erythrocytes containing mature parasite stages bind to…”
    Get more information
    Journal Article
  17. 17

    Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka by Gamage-Mendis, A C, Rajakaruna, J, Carter, R, Mendis, K N

    “…The infectious reservoir of Plasmodium vivax and P. falciparum in a malaria endemic region in Sri Lanka was defined in a population of 3,625 by directly…”
    Get more information
    Journal Article
  18. 18

    Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies by Mendis, C, Gamage-Mendis, A C, De Zoysa, A P, Abhayawardena, T A, Carter, R, Herath, P R, Mendis, K N

    “…Parasitological and entomological parameters of malaria transmission were monitored for 17 months in 3,625 residents in a Plasmodium vivax malaria endemic…”
    Get more information
    Journal Article
  19. 19

    Infectivity of Plasmodium vivax and P. falciparum to Anopheles tessellatus; relationship between oocyst and sporozoite development by Gamage-Mendis, A C, Rajakaruna, J, Weerasinghe, S, Mendis, C, Carter, R, Mendis, K N

    “…The assessment of malarial infectivity, for example in the evaluation of transmission blocking immunity, is generally based on counting oocysts in mosquitoes…”
    Get more information
    Journal Article
  20. 20

    Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka by Gamage-Mendis, A C, Rajakaruna, J, Carter, R, Mendis, K N

    Published in Parasite immunology (01-07-1992)
    “…Serum effects on gametocyte infectivity, that is, transmission blocking/enhancing immunity, were measured in the sera of 196 acute Plasmodium vivax patients…”
    Get more information
    Journal Article